P-253: Impact of adjusting bortezomib dose in the pomalidomide, bortezomib, and dexamethasone (PVd) combination: a post hoc analysis of the OPTIMISMM study

Autor:	Alessandra Larocca, Katja Weisel, Monica Galli, Albert Oriol, Thierry Facon, Sujith Dhanasiri, Kevin Hong, Christian Gentili, Yutian Mu, Shien Guo, Fredrik Schjesvold, Meletios A. Dimopoulos, Paul Richardson
Rok vydání:	2022
Předmět:	Cancer Research Oncology Hematology
Zdroj:	Clinical Lymphoma Myeloma and Leukemia. 22:S175
ISSN:	2152-2650
DOI:	10.1016/s2152-2650(22)00583-3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::276fec53b330e866efd2e237356fa6e8 https://doi.org/10.1016/s2152-2650(22)00583-3 Zobrazit plný text záznamu Full Text from ScienceDirect